Erratum: Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB (Molecular Brain Research (2004) 122 (167-179) DOI: 10.1016/j.molbrainres.2003.12.009);Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB

Molecular Brain Research

Volumn 122, Issue 2, 2004, Pages 167-179

  Barhoumi, Rola ^a   Faske, Jennifer ^a   Liu, Xuhong ^a   Tjalkens, Ronald B ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Disorders of the nervous system; Glia; Inducible nitric oxide synthase; Manganese; Mitochondria; Nitric oxide; Nuclear factor kappa beta; Signal transduction: gene expression

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANTIOXIDANT; CIS ACTING ELEMENT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN INTERACTING KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; LIPOPOLYSACCHARIDE; MANGANESE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOQ; MUTANT PROTEIN; NITRIC OXIDE; PROTEIN P50; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENUATION; BRAIN MITOCHONDRION; CALCIUM TRANSPORT; DRUG SELECTIVITY; GLIOMA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT;

EID: 1542358741     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.03.002     Document Type: Erratum

References (56)

1. Bernas T., Dobrucki J. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry. 47:2002;236-242.
2. Bhat N.R., Feinstein D.L., Shen Q., Bhat A.N. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. J. Biol. Chem. 277:2002;29584-29592.
3. Bolanos J.P., Heales S.J., Land J.M., Clark J.B. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64(5):1995;1965-1972.
4. Breuer W., Epsztejn S., Millgram P., Cabantchik I.Z. Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am. J. Physiol. 268:1995;1354-1361.
5. Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 120(1):1993;89-94.
6. Cano G., Suarez-Roca H., Bonilla E. Alterations of excitatory amino acid receptors in the brain of manganese-treated mice. Mol. Chem. Neuropathol. 30:1997;41-52.
7. Cardenas M.A., Moro O., Hurtado J.C., Leza P., Lorenzo A., Castrillo O.G., Bodelon L., Bosca L., Lizasoain I. Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. J. Neurochem. 74:2000;2041-2048.
8. Castrillo A., de Las Heras B., Hortelano S., Rodriguez B., Villar A., Bosca L. Inhibition of the nuclear factor kappa B (NF-kappa B) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF- kappa B-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK. J. Biol. Chem. 276:2001;15854-15860.
9. Cook D.G., Fahn S., Brait K.A. Chronic manganese intoxication. Arch. Neurol. 30(1):1974;59-64.
10. Dehmer T., Lindenau J., Haid S., Dichgans J., Schulz J.B. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 74:2000;2213-2216.
11. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22:1997;1115-1126.
12. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55:1996;259-272.
13. Gavin E., Gunter K.K., Gunter T.E. Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem. J. 266(2):1990;329-334.
14. Goldring C.E., Reveneau S., Algarte M., Jeannin J.F. In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. Nucleic Acids Res. 24:1996;1682-1687.
15. Gomez-Isla T., Irizarry M.C., Mariash A., Cheung B., Soto O., Schrump S., Sondel J., Kotilinek L., Day J., Schwarzschild M.A., Cha J.H., Newell K., Miller D.W., Ueda K., Young A.B., Hyman B.T., Ashe K.H. Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. Neurobiol. Aging. 24:2003;245-258.
16. Hearn A.S., Stroupe M.E., Cabelli D.E., Ramilo C.A., Luba J.P., Tainer J.A., Nick H.S., Silverman D.N. Catalytic and structural effects of amino acid substitution at histidine 30 in human manganese superoxide dismutase: insertion of valine C gamma into the substrate access channel. Biochemistry. 42:2003;2781-2789.
17. Hirsch E.C., Hunot S., Damier P., Faucheux B. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44:1998;S115-S120.
18. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B., Hirsch E.C. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19:1999;3440-3447.
19. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17:1997;9157-9164.
20. Iimuro Y., Nishiura T., Hellerbrand C., Behrns K.E., Schoonhoven R., Grisham J.W., Brenner D.A. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101:1998;802-811.
21. Iravani M.M., Kashefi K., Mander P., Rose S., Jenner P. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience. 110:2002;49-58.
22. Ivins J.K., Yurchenco P.D., Lander A.D. Regulation of neurite outgrowth by integrin activation. J. Neurosci. 20:2000;6551-6560.
23. Jiang X., Takahashi N., Matsui N., Tetsuka T., Okamoto T. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278:2003;919-926.
24. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev., Cancer. 2002;301-310.
25. Ke S., Rabson A.B., Germino J.F., Gallo M.A., Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J. Biol. Chem. 276:2001;39638-39644.
26. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A., Murphy M.P. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276:2001;4588-4596.
27. Kim Y.M., Ko C.B., Park Y.P., Kim Y.J., Paik S.G. Octamer motif is required for the NF-kappaB-mediated induction of the inducible nitric oxide synthase gene expression in RAW 264.7 macrophages. Mol. Cells. 9:1999;99-109.
28. Kohutnicka M., Lewandowska E., Kurkowska-Jastrzebska I., Czlonkowski A., Czlonkowska A. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology. 39:1998;167-180.
29. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70(13):1998;2446-2453.
30. Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 26(3-4):1999;463-471.
31. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Ca(2+)-induced mitochondrial membrane permeabilization: role of coenzyme Q redox state. Am. J. Physiol. 269(1):1995;141-147.
32. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Opening of the mitochondrial permeability transition pore by uncoupling or inorganic phosphate in the presence of Ca2+ is dependent on mitochondrial-generated reactive oxygen species. FEBS Lett. 378(2):1996;150-152.
33. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270:1995;7017-7020.
34. Lecanu L., Verrecchia C., Margaill I., Boulu R.G., Plotkine M. iNOS contribution to the NMDA-induced excitotoxic lesion in the rat striatum. Br. J. Pharmacol. 125:1998;584-590.
35. Lee J.K., Choi S.S., Won J.S., Suh H.W. The regulation of inducible nitric oxide synthase gene expression induced by lipopolysaccharide and tumor necrosis factor-alpha in C6 cells: involvement of AP-1 and NFkappaB. Life Sci. 73:2003;595-609.
36. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5(12):1999;1403-1409.
37. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
38. Marcus J.S., Karackattu S.L., Fleegal M.A., Sumners C. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia. 41:2003;152-160.
39. Maurizi M.R., Pinkofsky H.B., Ginsburg A. ADP, chloride ion, and metal ion binding to bovine brain glutamine synthetase. Biochemistry. 26:1987;5023-5031.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65(1-2):1983;55-63.
41. Nakano H., Shindo M., Sakon S., Nishinaka S., Mihara M., Yagita H., Okumura K. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3537-3542.
42. Nishiya T., Uehara T., Kaneko M., Nomura Y. Involvement of nuclear factor-kappaB (NF-kappaB) signaling in the expression of inducible nitric oxide synthase (iNOS) gene in rat C6 glioma cells. Biochem. Biophys. Res. Commun. 275:2000;268-273.
43. Nomura Y. NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci. 68:2001;1695-1701.
44. Poinat P., De Arcangelis A., Sookhareea S., Zhu X., Hedgecock E.M., Labouesse M., Georges-Labouesse E. A conserved interaction between beta1 integrin/PAT-3 and Nck-interacting kinase/MIG-15 that mediates commissural axon navigation in C. elegans. Curr. Biol. 12:2002;622-631.
45. Raspotnig G., Fauler G., Jantscher A., Windischhofer W., Schachl K., Leis H.J. Colorimetric determination of cell numbers by Janus green staining. Anal. Biochem. 275:1999;74-83.
46. Rosenstock H.A., Simons D.G., Meyer J.S. Chronic manganism. Neurologic and laboratory studies during treatment with levodopa. JAMA. 217(10):1971;1354-1358.
47. Sherer T.B., Betarbet R., Kim J.H., Greenamyre J.T. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci. Lett. 341:2003;87-90.
48. Spranger M., Schwab S., Desiderato S., Bonmann E., Krieger D., Fandrey J. Manganese augments nitric oxide synthesis in murine astrocytes: a new pathogenetic mechanism in manganism? Exp. Neurol. 149(1):1998;277-283.
49. Tjalkens R.B., Cook L.W., Petersen D.R. Formation and export of the glutathione conjugate of 4-hydroxy-2, 3-E-nonenal (4-HNE) in hepatoma cells. Arch. Biochem. Biophys. 361(1):1999;113-119.
50. Tomas-Camardiel M., Herrera A.J., Venero J.L., Cruz Sanchez-Hidalgo M., Cano J., Machado A. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats. Mol. Brain Res. 103:2002;116-129.
51. Verity M.A. Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology. 20(2-3):1999;489-497.
52. Werner E., Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J. Cell Biol. 158:2002;357-368.
53. Wszolek Z.K., Gwinn-Hardy K., Wszolek E.K., Muenter M.D., Pfeiffer R.F., Rodnitzky R.L., Uitti R.J., McComb R.D., Gasser T., Dickson D.W. Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism. Acta Neuropathol. 103:2002;344-350.
54. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22:2002;1763-1771.
55. Xie Q.W., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-gamma and bacterial lipopolysaccharide. Trans. Assoc. Am. Physicians. 106:1993;1-12.
56. Zwingmann C., Leibfritz D., Hazell A.S. Energy metabolism in astrocytes and neurons treated with manganese: relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. J. Cereb. Blood Flow Metab. 23:2003;756-771.